tiprankstipranks
Advertisement
Advertisement
Boston Scientific Targets Diabetes and Obesity With New ESG Trial
PremiumCompany AnnouncementsBoston Scientific Targets Diabetes and Obesity With New ESG Trial
13d ago
Boston Scientific’s RESCUE Study Termination: What It Means for ESG and Obesity Investments
Premium
Company Announcements
Boston Scientific’s RESCUE Study Termination: What It Means for ESG and Obesity Investments
13d ago
Truist’s Travis Steed Reiterates Buy on Boston Scientific, Citing Underappreciated Watchman Upside and Maintaining $68 Price Target
Premium
Ratings
Truist’s Travis Steed Reiterates Buy on Boston Scientific, Citing Underappreciated Watchman Upside and Maintaining $68 Price Target
14d ago
Boston Scientific price target lowered to $70 from $71 at Canaccord
PremiumThe FlyBoston Scientific price target lowered to $70 from $71 at Canaccord
22d ago
Why The Most Dominant Businesses Have Quietly Beaten the Market for Decades: Inside the Monopoly ETF (MPLY)
Premium
Market NewsSponsored
Why The Most Dominant Businesses Have Quietly Beaten the Market for Decades: Inside the Monopoly ETF (MPLY)
22d ago
SPDR S&P 500 ETF Trust (SPY) Daily Update, 5/29/2026
Premium
Market News
SPDR S&P 500 ETF Trust (SPY) Daily Update, 5/29/2026
25d ago
SPDR S&P 500 ETF Trust (SPY) Daily Update, 5/28/2026
PremiumMarket NewsSPDR S&P 500 ETF Trust (SPY) Daily Update, 5/28/2026
26d ago
Boston Scientific Advances FARAPULSE PFA Study in Atrial Fibrillation
Premium
Company Announcements
Boston Scientific Advances FARAPULSE PFA Study in Atrial Fibrillation
26d ago
Boston Scientific Nears Key Data Milestone in Painful Diabetic Neuropathy Trial
Premium
Company Announcements
Boston Scientific Nears Key Data Milestone in Painful Diabetic Neuropathy Trial
26d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100